KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Asset Writedowns and Impairment (2023 - 2025)

QuidelOrtho's Asset Writedowns and Impairment history spans 3 years, with the latest figure at $9.7 million for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $9.7 million; the TTM value through Sep 2025 reached $9.7 million, down 83.94%, while the annual FY2025 figure was $9.7 million, 82.95% down from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 was $9.7 million at QuidelOrtho, down from $56.9 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $56.9 million in Q2 2024 and bottomed at $1.3 million in Q4 2023.
  • The 3-year median for Asset Writedowns and Impairment is $5.9 million (2023), against an average of $17.5 million.